Kenneth A Bauer Selected Research

Enoxaparin (Lovenox)

1/2020	Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: a randomized, double-blinded multicenter phase 2 trial.
2/2013	Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study).
1/2009	Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial.
1/2008	Timing of postpartum enoxaparin administration and severe postpartum hemorrhage.
6/2007	Rivaroxaban for thromboprophylaxis after orthopaedic surgery: pooled analysis of two studies.
1/2006	New anticoagulants.
8/2004	Superiority of fondaparinux over enoxaparin in preventing venous thromboembolism in major orthopedic surgery using different efficacy end points.
12/2003	New pentasaccharides for the prophylaxis of venous thromboembolism: clinical studies.
9/2003	Fondaparinux, the first selective factor Xa inhibitor.
11/2002	Fondaparinux: basic properties and efficacy and safety in venous thromboembolism prophylaxis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenneth A Bauer Research Topics

Disease

36	Venous Thromboembolism 01/2024 - 01/2002
24	Hemorrhage 01/2022 - 01/2002
15	Thrombosis (Thrombus) 01/2024 - 01/2002
14	Venous Thrombosis (Deep-Vein Thrombosis) 12/2020 - 01/2002
8	Neoplasms (Cancer) 01/2020 - 11/2009
6	Thrombophilia 12/2023 - 10/2005
6	Pulmonary Embolism 11/2020 - 08/2004
5	Thrombocytopenia (Thrombopenia) 10/2020 - 12/2003
5	Atrial Fibrillation 01/2019 - 01/2006
3	Wounds and Injuries (Trauma) 11/2018 - 01/2010
3	Stroke (Strokes) 01/2013 - 01/2006
3	Acute Coronary Syndrome 01/2006 - 09/2003
3	Thromboembolism 10/2004 - 05/2002
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2020 - 10/2017
2	Critical Illness (Critically Ill) 01/2020 - 11/2018
2	hereditary Thrombophilia 01/2007 - 12/2004
2	Myocardial Infarction 08/2006 - 10/2003
1	Protein S Deficiency (Deficiency, Protein S) 12/2023
1	Type 2 von Willebrand Disease 12/2023
1	Postthrombotic Syndrome 12/2020
1	Clinical Deterioration 12/2020
1	COVID-19 10/2020
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2020
1	Abdominal Aortic Aneurysm 01/2019
1	Flank Pain 01/2019
1	Vascular System Injuries 01/2019
1	Craniocerebral Trauma (Head Injury) 10/2017
1	Traumatic Intracranial Hemorrhage 10/2017
1	Antithrombin III Deficiency 01/2016
1	Hemophilia A (Haemophilia) 03/2015
1	Hereditary Angioedemas 11/2014
1	Body Weight (Weight, Body) 01/2013
1	Ischemic Stroke 07/2010
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2009

Drug/Important Bio-Agent (IBA)

17	Fondaparinux (Arixtra)FDA Link 09/2008 - 01/2002
16	Enoxaparin (Lovenox)FDA LinkGeneric 01/2020 - 01/2002
12	AnticoagulantsIBA 01/2020 - 10/2005
9	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2020 - 01/2002
8	AntithrombinsIBA 01/2020 - 03/2003
7	Heparin (Liquaemin)FDA LinkGeneric 10/2020 - 06/2002
6	Prothrombin (Factor II)IBA 01/2024 - 01/2002
6	Factor Xa InhibitorsIBA 01/2022 - 01/2002
6	RivaroxabanIBA 01/2019 - 06/2007
5	factor V LeidenIBA 01/2024 - 01/2002
5	fibrin fragment D (D-dimer)IBA 12/2023 - 01/2015
5	Factor Xa (Coagulation Factor Xa)IBA 01/2022 - 05/2002
5	Vitamin K FDA Link 04/2011 - 10/2004
4	Warfarin (Coumadin)FDA LinkGeneric 01/2013 - 04/2003
3	Thromboplastin (Tissue Factor)IBA 02/2013 - 10/2002
3	Thrombin FDA Link 01/2013 - 10/2002
2	von Willebrand FactorIBA 12/2023 - 08/2006
2	PRT064445IBA 01/2022 - 01/2019
2	Antiphospholipid AntibodiesIBA 10/2018 - 10/2005
2	Dabigatran FDA Link 06/2013 - 01/2013
2	Factor VII (Proconvertin)IBA 07/2010 - 10/2005
2	melagatranIBA 02/2006 - 01/2006
2	argatroban (MPQA)FDA Link 02/2006 - 01/2006
2	ProdrugsIBA 02/2006 - 01/2006
2	lepirudin (Refludan)FDA Link 02/2006 - 01/2006
2	ximelagatran (Exanta)IBA 02/2006 - 01/2006
1	Protein CIBA 12/2023
1	Factor VIII (Coagulation Factor VIII)IBA 12/2023
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 12/2020
1	AntibodiesIBA 10/2020
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Protein Disulfide-IsomerasesIBA 01/2019
1	FibrinIBA 01/2019
1	FlavonoidsIBA 01/2019
1	IsomerasesIBA 01/2019
1	isoquercitrinIBA 01/2019
1	QuercetinIBA 01/2019
1	Sulfhydryl Compounds (Thiols)IBA 01/2019
1	Estrogens (Estrogen)FDA Link 01/2016
1	Blood Coagulation Factors (Coagulation Factor)IBA 03/2015
1	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 11/2014
1	apixabanIBA 01/2013
1	Diclofenac (SR 38)FDA LinkGeneric 11/2010
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 11/2010
1	KetorolacIBA 11/2010
1	Investigational DrugsIBA 03/2010
1	AntigensIBA 05/2009
1	Tyr sulfate(1)- enkephalinamide-Leu (LETS)IBA 05/2009
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 05/2009
1	betrixabanIBA 01/2009

Therapy/Procedure

16	Therapeutics 12/2020 - 01/2002
9	Orthopedic Procedures 08/2004 - 01/2002
2	Knee Replacement Arthroplasty (Total Knee Replacement) 01/2013 - 01/2009
1	Replacement Arthroplasty 01/2022
1	Thrombolytic Therapy 12/2020
1	Thrombectomy 12/2020
1	Catheters 12/2020
1	Chemoprevention 01/2020
1	Critical Care (Surgical Intensive Care) 01/2020
1	Long-Term Care 11/2018
1	Lymph Node Excision (Lymph Node Dissection) 11/2014
1	Secondary Prevention 01/2013
1	Injections 01/2013
1	Length of Stay 01/2009